XTRA:GXILife Sciences
Gerresheimer (XTRA:GXI) Stock Faces Margin Squeeze As EPS Loss Challenges Bullish Narratives
Gerresheimer (XTRA:GXI) has released its FY 2025 third quarter numbers, reporting revenue of €560.7 million and a loss per share of €0.37, with net income excluding extra items showing a loss of €12.7 million. The company has seen quarterly revenue move from €498.5 million in Q3 2024 to €560.7 million in Q3 2025, while basic EPS shifted from €0.79 in Q3 2024 to a loss of €0.37 in Q3 2025. This sets up a results season in which investors are weighing modest top line progress against thinner...